JPMorgan Chase & Co. reissued their overweight rating on shares of Reckitt Benckiser Group (LON:RB) in a report released on Tuesday morning.
Other research analysts have also recently issued reports about the stock. UBS Group restated a neutral rating and set a GBX 6,300 ($82.32) price target (down from GBX 6,400 ($83.63)) on shares of Reckitt Benckiser Group in a report on Friday, October 26th. Liberum Capital restated a buy rating on shares of Reckitt Benckiser Group in a report on Friday, October 19th. Credit Suisse Group set a GBX 5,850 ($76.44) price target on shares of Reckitt Benckiser Group and gave the stock a sell rating in a report on Wednesday, September 19th. Royal Bank of Canada set a GBX 5,100 ($66.64) price target on shares of Reckitt Benckiser Group and gave the stock a sell rating in a report on Monday, November 5th. Finally, Goldman Sachs Group boosted their price target on shares of Reckitt Benckiser Group from GBX 7,025 ($91.79) to GBX 7,090 ($92.64) and gave the stock a neutral rating in a report on Tuesday, October 30th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have given a buy rating to the stock. The company presently has an average rating of Hold and an average target price of GBX 7,060 ($92.25).
Shares of LON RB opened at GBX 6,169 ($80.61) on Tuesday. Reckitt Benckiser Group has a 1 year low of GBX 5,562 ($72.68) and a 1 year high of GBX 8,110.43 ($105.98).
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.
Recommended Story: Conference Calls
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.